GSK Investigational Site

Szentes 6600

0 studies enrolling now · 5 studies all time

What they study most

Arthritis, Rheumatoid, Diabetes Mellitus, Type 2, Nausea and Vomiting, Postoperative, Postoperative Nausea and Vomiting

Studies at this site

• Long-term Safety and Efficacy of GSK3196165 (Otilimab) in the Treatment of Rheumatoid Arthritis (RA) — Stopped early
• Efficacy and Safety of GSK3196165 Versus Placebo and Tofacitinib in Participants With Moderately to Severely Active Rheumatoid Arthritis Who Have an Inadequate Response to Conventional Synthetic (cs)/Biologic (b) Disease Modifying Anti-rheumatic Drugs (DMARDs) — Stopped early
• Dose-Ranging Study in Treatment Naive Type 2 Diabetes Mellitus(T2DM) — Completed
• Post-Operative Nausea And Vomiting Study In Female Patients — Completed
• Casopitant (Oral) And ZOFRAN To Prevent Postoperative Nausea And Vomiting In Women — Completed